These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Induction of Mitochondrial Dysfunction and Oxidative Damage by Antibiotic Drug Doxycycline Enhances the Responsiveness of Glioblastoma to Chemotherapy. Tan Q; Yan X; Song L; Yi H; Li P; Sun G; Yu D; Li L; Zeng Z; Guo Z Med Sci Monit; 2017 Aug; 23():4117-4125. PubMed ID: 28842551 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer. Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219 [TBL] [Abstract][Full Text] [Related]
10. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Cox AG; Brown KK; Arner ES; Hampton MB Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312 [TBL] [Abstract][Full Text] [Related]
11. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species. Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611 [TBL] [Abstract][Full Text] [Related]
12. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach. Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488 [TBL] [Abstract][Full Text] [Related]
13. Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug. Kast RE Cent Eur Neurosurg; 2010 Aug; 71(3):139-42. PubMed ID: 20127591 [No Abstract] [Full Text] [Related]
14. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation. Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276 [TBL] [Abstract][Full Text] [Related]
15. SK channel activation is neuroprotective in conditions of enhanced ER-mitochondrial coupling. Honrath B; Krabbendam IE; IJsebaart C; Pegoretti V; Bendridi N; Rieusset J; Schmidt M; Culmsee C; Dolga AM Cell Death Dis; 2018 May; 9(6):593. PubMed ID: 29789578 [TBL] [Abstract][Full Text] [Related]
16. Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative. Rigobello MP; Scutari G; Boscolo R; Bindoli A Br J Pharmacol; 2002 Aug; 136(8):1162-8. PubMed ID: 12163349 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines. Abdulkareem ZA; Gee JM; Cox CD; Wann KT Br J Pharmacol; 2016 Jan; 173(1):177-90. PubMed ID: 26454020 [TBL] [Abstract][Full Text] [Related]
18. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma. Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells. Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084 [TBL] [Abstract][Full Text] [Related]
20. Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Rigobello MP; Folda A; Baldoin MC; Scutari G; Bindoli A Free Radic Res; 2005 Jul; 39(7):687-95. PubMed ID: 16036347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]